Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma

BACKGROUND: A pilot study of stereotactic body radiation therapy (SBRT) followed by high-dose interleukin-2 (IL-2) showed a higher than anticipated objective response rate (ORR) among patients with metastatic melanoma (MM). We performed a prospective randomized study to determine if the ORR of SBRT...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Immunother Cancer
Glavni autori: Curti, Brendan, Crittenden, Marka, Seung, Steven K, Fountain, Christopher B, Payne, Roxanne, Chang, ShuChing, Fleser, Jessica, Phillips, Kimberly, Malkasian, Ian, Dobrunick, Lyn B, Urba, Walter J
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2020
Teme:
Clinical/Translational Cancer Immunotherapy
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7259841/
https://ncbi.nlm.nih.gov/pubmed/32467299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000773
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items